Anti‐infective Agents: The Example of Antibacterial Drug Leads
Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardiz...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Buchkapitel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 122 |
---|---|
container_issue | |
container_start_page | 109 |
container_title | |
container_volume | |
creator | Macedo, Maíra Bidart Clais, Sofie Lanckacker, Ellen Maes, Louis Lima, Emerson Silva Cos, Paul |
description | Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria. |
doi_str_mv | 10.1002/9781118930717.ch11 |
format | Book Chapter |
fullrecord | <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_ebooks_10_1002_9781118930717_ch11_ch11</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10.1002/9781118930717.ch11</sourcerecordid><originalsourceid>FETCH-LOGICAL-s238f-e62e9401e75b72cb7448b33938e0ad963c7dbc3f36be396184f1fb5503d5beaa3</originalsourceid><addsrcrecordid>eNptkE1KxEAQhVtEUMdcwFVfILErlaS7XRnG8QcCbsZ16E6qZ6IxGabj78ojeEZPolERFTf1oHjfg_cY2wcRgRDxgZYKAJRGIUFG1RJgg-1-f2CTBT8cidpmgfdXQghIM9CQ7bCjvBua1-eXpnNUDc0d8XxB3eAP-XxJfPZgblYt8d7x0WdNNdC6MS0_Xt8ueEGm9ntsy5nWU_ClE3Z5MptPz8Li4vR8mhehj1G5kLKYdCKAZGplXFmZJMoialQkTK0zrGRtK3SYWUKdgUocOJumAuvUkjE4YdFn7n3T0mNJtu-vffmrf_nUrMpxg3JVu3cA_wFAlONwf8APaDz4BsGeYDk</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>book_chapter</recordtype></control><display><type>book_chapter</type><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><source>eBooks on EBSCOhost</source><creator>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul</creator><contributor>Jäger, Anna K ; Heinrich, Michael</contributor><creatorcontrib>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul ; Jäger, Anna K ; Heinrich, Michael</creatorcontrib><description>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</description><identifier>ISBN: 9781118930748</identifier><identifier>ISBN: 1118930746</identifier><identifier>EISBN: 1118930711</identifier><identifier>EISBN: 9781118930717</identifier><identifier>DOI: 10.1002/9781118930717.ch11</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>antibacterial ; anti‐infective ; biofilms ; resistance‐modifying agents ; virulence</subject><ispartof>Ethnopharmacology, 2015, p.109-122</ispartof><rights>Copyright © 2015 John Wiley & Sons, Ltd</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,781,785,794,27930</link.rule.ids></links><search><contributor>Jäger, Anna K</contributor><contributor>Heinrich, Michael</contributor><creatorcontrib>Macedo, Maíra Bidart</creatorcontrib><creatorcontrib>Clais, Sofie</creatorcontrib><creatorcontrib>Lanckacker, Ellen</creatorcontrib><creatorcontrib>Maes, Louis</creatorcontrib><creatorcontrib>Lima, Emerson Silva</creatorcontrib><creatorcontrib>Cos, Paul</creatorcontrib><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><title>Ethnopharmacology</title><description>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</description><subject>antibacterial</subject><subject>anti‐infective</subject><subject>biofilms</subject><subject>resistance‐modifying agents</subject><subject>virulence</subject><isbn>9781118930748</isbn><isbn>1118930746</isbn><isbn>1118930711</isbn><isbn>9781118930717</isbn><fulltext>true</fulltext><rsrctype>book_chapter</rsrctype><creationdate>2015</creationdate><recordtype>book_chapter</recordtype><sourceid/><recordid>eNptkE1KxEAQhVtEUMdcwFVfILErlaS7XRnG8QcCbsZ16E6qZ6IxGabj78ojeEZPolERFTf1oHjfg_cY2wcRgRDxgZYKAJRGIUFG1RJgg-1-f2CTBT8cidpmgfdXQghIM9CQ7bCjvBua1-eXpnNUDc0d8XxB3eAP-XxJfPZgblYt8d7x0WdNNdC6MS0_Xt8ueEGm9ntsy5nWU_ClE3Z5MptPz8Li4vR8mhehj1G5kLKYdCKAZGplXFmZJMoialQkTK0zrGRtK3SYWUKdgUocOJumAuvUkjE4YdFn7n3T0mNJtu-vffmrf_nUrMpxg3JVu3cA_wFAlONwf8APaDz4BsGeYDk</recordid><startdate>20150918</startdate><enddate>20150918</enddate><creator>Macedo, Maíra Bidart</creator><creator>Clais, Sofie</creator><creator>Lanckacker, Ellen</creator><creator>Maes, Louis</creator><creator>Lima, Emerson Silva</creator><creator>Cos, Paul</creator><general>John Wiley & Sons, Ltd</general><scope/></search><sort><creationdate>20150918</creationdate><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><author>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s238f-e62e9401e75b72cb7448b33938e0ad963c7dbc3f36be396184f1fb5503d5beaa3</frbrgroupid><rsrctype>book_chapters</rsrctype><prefilter>book_chapters</prefilter><language>eng</language><creationdate>2015</creationdate><topic>antibacterial</topic><topic>anti‐infective</topic><topic>biofilms</topic><topic>resistance‐modifying agents</topic><topic>virulence</topic><toplevel>online_resources</toplevel><creatorcontrib>Macedo, Maíra Bidart</creatorcontrib><creatorcontrib>Clais, Sofie</creatorcontrib><creatorcontrib>Lanckacker, Ellen</creatorcontrib><creatorcontrib>Maes, Louis</creatorcontrib><creatorcontrib>Lima, Emerson Silva</creatorcontrib><creatorcontrib>Cos, Paul</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Macedo, Maíra Bidart</au><au>Clais, Sofie</au><au>Lanckacker, Ellen</au><au>Maes, Louis</au><au>Lima, Emerson Silva</au><au>Cos, Paul</au><au>Jäger, Anna K</au><au>Heinrich, Michael</au><format>book</format><genre>bookitem</genre><ristype>CHAP</ristype><atitle>Anti‐infective Agents: The Example of Antibacterial Drug Leads</atitle><btitle>Ethnopharmacology</btitle><date>2015-09-18</date><risdate>2015</risdate><spage>109</spage><epage>122</epage><pages>109-122</pages><isbn>9781118930748</isbn><isbn>1118930746</isbn><eisbn>1118930711</eisbn><eisbn>9781118930717</eisbn><abstract>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><doi>10.1002/9781118930717.ch11</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISBN: 9781118930748 |
ispartof | Ethnopharmacology, 2015, p.109-122 |
issn | |
language | eng |
recordid | cdi_wiley_ebooks_10_1002_9781118930717_ch11_ch11 |
source | eBooks on EBSCOhost |
subjects | antibacterial anti‐infective biofilms resistance‐modifying agents virulence |
title | Anti‐infective Agents: The Example of Antibacterial Drug Leads |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T21%3A51%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=bookitem&rft.atitle=Anti%E2%80%90infective%20Agents:%20The%20Example%20of%20Antibacterial%20Drug%20Leads&rft.btitle=Ethnopharmacology&rft.au=Macedo,%20Ma%C3%ADra%20Bidart&rft.date=2015-09-18&rft.spage=109&rft.epage=122&rft.pages=109-122&rft.isbn=9781118930748&rft.isbn_list=1118930746&rft_id=info:doi/10.1002/9781118930717.ch11&rft_dat=%3Cwiley%3E10.1002/9781118930717.ch11%3C/wiley%3E%3Curl%3E%3C/url%3E&rft.eisbn=1118930711&rft.eisbn_list=9781118930717&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |